-
-
Overview
-
Trastuzumab is a recombinant humanized monoclonal antibody that is used in the treatment of cancer.
This product comes in a liquid form with a protein content of >15 mg/mL.Please contact us at for specific academic pricing.
Background
HER2 is a receptor tyrosine kinase and epidermal growth factor which overexpresses in breast cancer cells causing over-proliferation. Trastuzumab targets the extracellular domain IV of HER2, keeping it from dimerizing and activating.
-
- Properties
-
Overview